Director/PDMR Shareholding

RNS Number : 1949Q

NetScientific PLC

27 June 2022

 

      NetScientific plc

Director/PDMR Shareholding

NetScientific plc (AIM:NSCI) (the "Company"), the transatlantic healthcare IP commercialisation group, announced on 22 June 2022, that it had closed its Placing of 2,238,807 Placing Shares at a Placing Price of 67 pence per Placing Share.

Dr Ilian Iliev and Mr John Clarkson (each a Director of the Company) and Mr Stephen Crowe (CFO) each participated in the Placing and as persons discharging managerial responsibilities in respect of the Company details of their participation are set out below.

Unless otherwise defined, terms used in this announcement shall have the same meanings as those defined in the Company's announcement dated 22 June 2022.

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Ilian Petkov Iliev
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	NetScientific plc
b)	LEI	213800N5WD46G1Y7I458
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.05 each GB00BN4R5Q82
b)	Nature of the transaction	Participation in placement
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.67 21,641 Ordinary Shares
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	27 June 2022
f)	Place of the transaction	UK AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	John Eric Clarkson
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	NetScientific plc
b)	LEI	213800N5WD46G1Y7I458
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.05 each GB00BN4R5Q82
b)	Nature of the transaction	Participation in placement
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.67 59,701 Ordinary Shares
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	27 June 2022
f)	Place of the transaction	UK AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Stephen Daniel Crowe
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	NetScientific plc
b)	LEI	213800N5WD46G1Y7I458
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.05 each GB00BN4R5Q82
b)	Nature of the transaction	Participation in placement
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.67 22,388 Ordinary Shares
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	27 June 2022
f)	Place of the transaction	UK AIM

About NetScientific

NetScientific plc (AIM: NSCI) is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential in the UK, Europe and USA, as well as globally. 

Since the adoption of the New Strategy in 2020, the Group has nearly trebled its portfolio from 8 to 22 companies, either through subsidiary, direct balance sheet investment or capital under advisory.

NetScientific delivers shareholder returns through a proactive and hands-on management approach to their portfolio companies; identifying, investing in, and helping to build game-changing companies. The Group targets value inflection points and the release of value through partial or full exits from trade sales, public listings, or equity sales. The Company has a strong transatlantic and growing international presence, providing attractive expansion prospects. 

NSCI can deploy a capital-light investment structure; utilising the power of the PLC Brand, and the NetScientific balance sheet to anchor future investments and achieve a multiplier effect by attracting third party investment for the portfolio companies. 

NetScientific is headquartered in London, United Kingdom, and was admitted to trading on AIM, a market operated by the London Stock Exchange, in 2013 (website:  www.netscientific.net ).

 

END

 

 

DSHSEWFMLEESEEM